FAQs

What dividend was decided for fiscal year 2010?

The Annual Shareholder’s Meeting of June 16, 2011 has decided, for the financial year 2010, a dividend of an amount of EUR 0.37 per common share.¹⁾

In comparison to the year-end 2009, the number of shares entitled to a dividend at the year-end 2010 increased slightly due to the conversion of STADA warrants 2000/2015 by 58,876,360 shares; STADA also held at the end of the year 2010 100,706 shares not entitled to a dividend. This results in total dividend payments in the amount of EUR 21.7 million (previous year: EUR 32.3 million).

The distribution ratio thus amounts to approx. 32% of net income (previous year: approx. 32%).²⁾

The aim of the proposal is to allow shareholders to participate in net earnings, without placing too great a restriction on the Group’s financial flexibility for further growth.

Information on the Shareholders' Meeting

1)	See the Company’s ad hoc release of February 28, 2011.
2)	Dividend ratio in terms of unappropriated retained earnings of STADA Arzneimittel AG approx. 90% (previous year: approx. 99%).

Company profile

Here we have provided you with an overview of important facts and information from strategy through business segments, sales networks and the history of STADA Arzneimittel AG. More

Management

The management of STADA Arzneimittel AG introduce themselves! Here you will find the members of the Executive Board, the Supervisory Board and the Advisory Board. More

Ad hoc & press releases

Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More

Disclosures to WpHG/WpPG

Notices in accordance with the German Securities Trading Act (WpHG) as well as the annual document and the annual financial statements of STADA Arzneimittel AG can be viewed here. More